Akebia Therapeutics Inc (AKBA) Stock Price, Quote, News & History

AKBANASDAQ
$1.43
N/A
At close: Apr 24, 5:00 PM EST
$1.43
0.00260.18%
After Hours: 4:51 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
67.99M
Investing Cash Flow (TTM)
-7.93M
Financing Cash Flow (TTM)
72.93M
Free Cash Flow (TTM)
59.89M
Capital Expenditure (TTM)
-8.10M
Net Change in Cash (TTM)
132.99M

Analyst Trends and Forecast

2
Oct 25
2
Dec 25
3
Feb
1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$252.70M
PE Ratio (TTM)
-
PE Ratio (FWD)
35.97
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.57
PB Ratio (TTM)
11.83
Earnings Yield % (TTM)
-1.39%
Earnings Yield % (FWD)
2.78%
EV / EBITDA (TTM)
11.63
Price / EBITDA (TTM)
17.04
Price / Free Cash Flow (TTM)
6.18
Book Value / Share
$0.12

Company Debt

Total Debt
$48.25M
LT Debt
$48.25M
LT Debt Issuance (TTM)
$10.00M
LT Debt Repayment (TTM)
-$462.00K
Total Cash
$184.84M
Debt to Equity
1.59
Issuance of Debt (TTM)
$9.54M
Repayment of Debt (TTM)
-$462.00K

Key Statistics

Open
$1.42
Close
$1.43
Volume / Avg.
2.38M / 3.04M
Day Range
$1.41 - $1.45
52 Wk Range
1.14 - 4.08
Market Cap
$380.16M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
10%
Days to Cover
9.34

About

Sector
Health Care
Industry
Biotechnology
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a m...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Akebia Therapeutics (AKBA) stock?

A

You can purchase shares of Akebia Therapeutics (NASDAQ:AKBA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Akebia Therapeutics (AKBA) competitors?

Q

What is the forecast, or price target, for Akebia Therapeutics (AKBA) stock?

A

Akebia Therapeutics has a consensus price target of $5.50.

Q

What is the current price for Akebia Therapeutics (AKBA)?

A

The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $1.4326 last updated April 24, 2026 at 4:51 PM EDT.

Q

Does Akebia Therapeutics (AKBA) pay a dividend?

A

There are no upcoming dividends for Akebia Therapeutics.

Q

When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?

A

Akebia Therapeutics does not have any upcoming earnings scheduled.

Q

Is Akebia Therapeutics (AKBA) going to split?

A

There is no upcoming split for Akebia Therapeutics.

Q

What sector and industry does Akebia Therapeutics (AKBA) operate in?

A

Akebia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.